Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.
《内分泌相关癌症》是内分泌学会的官方旗舰期刊，并得到欧洲内分泌学会、英国和爱尔兰神经内分泌学会以及日本激素和癌症学会的认可。内分泌相关癌症为发表高质量原创文章提供了一个独特的国际论坛，这些文章描述了针对内分泌肿瘤和激素依赖性癌症的人类健康和疾病的新颖、前沿的基础实验室、转化和临床研究;内分泌肿瘤包括肾上腺皮质癌、乳腺癌、多发性内分泌肿瘤、神经内分泌肿瘤、卵巢癌、前列腺癌、副神经节瘤、甲状旁腺癌、嗜铬细胞瘤、垂体癌、睾丸癌、甲状腺癌和激素依赖癌。还考虑影响代谢和能量产生的肿瘤，如膀胱、骨、肾、肺和头颈部。
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-17-0562
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0574
Oxidative stress in thyroid carcinomas: biological and clinical significance.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0476
FAM129A regulates autophagy in thyroid carcinomas in an oncogene-dependent manner.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-17-0530
Antitumor effects of anlotinib in thyroid cancer
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-17-0558
Clock genes and cancer development in particular in endocrine tissues.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0094
Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-19-0347
Management of carcinoid syndrome: a systematic review and meta-analysis.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0495
PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0011
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0258
Interplay between the androgen receptor signalling axis and microRNAs in prostate cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0571
Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0354
Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0074
The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0175
lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0552
Non-canonical AR activity facilitates endocrine resistance in breast cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0333
Radioactive iodine in differentiated thyroid cancer: a national database perspective.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0292
Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0420
Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0337
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
来源期刊：Endocrine-related cancerDOI：10.1530/erc-19-0400
Host CYP27A1 expression is essential for ovarian cancer progression.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0572
Parental obesity programs pancreatic cancer development in offspring.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0016
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0420
Lobectomy in patients with differentiated thyroid cancer: indications and follow-up.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0085
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0442
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0107
ATM deficiency promotes progression of CRPC by enhancing Warburg effect.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0196
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0507
Thyroxine promotes lung cancer growth in an orthotopic mouse model.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0353
Tales from topographic oceans: topologically associated domains and cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0348
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0300
Estrogen receptor-α regulates the expression of syndecan-1 in human breast carcinoma cells.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0285
Reciprocal interplay of miR-497 and MALAT1 promotes tumourigenesis of adrenocortical cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0036
Diagnosis and management of primary bilateral macronodular adrenal hyperplasia
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0240
Oncometabolite induced primary cilia loss in pheochromocytoma
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-18-0134
Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0555
Metabolomics signatures of a subset of RET variants according to their oncogenic risk level.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0314
Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism
来源期刊：Endocrine-related CancerDOI：10.1530/ERC-18-0385
Tumor expression of environmental chemical-responsive genes and breast cancer mortality.
来源期刊：Endocrine-related cancerDOI：10.1530/erc-19-0357
Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0370
Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0465
FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-19-0156
Calcitonin induces stem cell-like phenotype in prostate cancer cells.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0333
A lex naturalis delineates components of a human-specific, adrenal androgen-dependent, p53-mediated ‘kill switch’ tumor suppression mechanism
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-19-0382
Genetic susceptibility to radiation-related thyroid cancer: a systematic review.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0321
Gastric neuroendocrine neoplasias: manifestations and comparative outcomes
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-18-0582
Thyrotoxicosis with concomitant thyroid cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-19-0129
Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-18-0393
The ERβ5 splice variant increases oestrogen responsiveness of ERαpos Ishikawa cells
来源期刊：Endocrine-Related CancerDOI：10.1530/ERC-19-0291
MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer.
来源期刊：Endocrine-related cancerDOI：10.1530/ERC-18-0500
